See more : RNI Negócios Imobiliários S.A. (RDNI3.SA) Income Statement Analysis – Financial Results
Complete financial analysis of Ajooni Biotech Limited (AJOONI.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ajooni Biotech Limited, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Pony Group Inc. (PNYG) Income Statement Analysis – Financial Results
- Canterbury Park Holding Corporation (CPHC) Income Statement Analysis – Financial Results
- Huayu Expressway Group Limited (1823.HK) Income Statement Analysis – Financial Results
- Town Health International Medical Group Limited (3886.HK) Income Statement Analysis – Financial Results
- Fortress Biotech, Inc. (FBIOP) Income Statement Analysis – Financial Results
Ajooni Biotech Limited (AJOONI.NS)
About Ajooni Biotech Limited
Ajooni Biotech Limited manufactures and sells animal feed in India. The company offers cattle feeds and feed supplements. Ajooni Biotech Limited was incorporated in 2010 and is based in Mohali, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 801.15M | 744.88M | 740.38M | 510.39M | 400.33M | 397.18M | 423.74M | 285.34M | 132.28M | 72.10M | 5.70M | 0.00 |
Cost of Revenue | 703.50M | 657.43M | 640.13M | 430.13M | 349.12M | 364.72M | 376.89M | 243.61M | 109.86M | 58.66M | 4.34M | 0.00 |
Gross Profit | 97.65M | 87.45M | 100.24M | 80.26M | 51.21M | 32.46M | 46.85M | 41.72M | 22.42M | 13.44M | 1.35M | 0.00 |
Gross Profit Ratio | 12.19% | 11.74% | 13.54% | 15.73% | 12.79% | 8.17% | 11.06% | 14.62% | 16.95% | 18.64% | 23.74% | 0.00% |
Research & Development | 670.00K | 2.42M | 497.53K | 699.02K | 2.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 7.92M | 5.44M | 4.07M | 6.70M | 3.08M | 3.52M | 9.59M | 446.00K | 198.00K | 52.00K | 26.00K | 5.00K |
Selling & Marketing | 24.46M | 15.05M | 25.26M | 27.17M | 12.44M | 6.02M | 2.37M | 15.15M | 9.91M | 5.52M | 253.00K | 0.00 |
SG&A | 32.38M | 20.49M | 29.33M | 33.87M | 15.52M | 9.53M | 11.96M | 15.59M | 10.11M | 5.58M | 279.00K | 5.00K |
Other Expenses | 64.60M | 2.94M | 375.74K | 169.97K | 193.08K | 681.40K | 149.28K | 20.87M | 10.71M | 6.83M | 950.00K | 5.00K |
Operating Expenses | 97.65M | 69.84M | 78.00M | 68.13M | 42.31M | 28.35M | 39.36M | 36.46M | 20.81M | 12.41M | 1.23M | 10.00K |
Cost & Expenses | 786.23M | 727.27M | 718.13M | 498.26M | 391.43M | 393.07M | 416.25M | 280.07M | 130.67M | 71.06M | 5.57M | 10.00K |
Interest Income | 5.01M | 2.05M | 5.55K | 2.14K | 727.45K | 4.73K | 1.36M | 1.21M | 6.00K | 35.00K | 0.00 | 0.00 |
Interest Expense | 5.57M | 4.78M | 5.39M | 4.94M | 3.15M | 1.09M | 0.00 | 0.00 | 172.00K | 8.00K | 0.00 | 0.00 |
Depreciation & Amortization | 8.74M | 10.05M | 11.11M | 5.78M | 4.92M | 2.97M | 3.15M | 1.91M | 721.00K | 315.00K | 1.00K | 9.00K |
EBITDA | 44.27M | 30.60M | 31.12M | 15.77M | 12.48M | 7.56M | 10.79M | 7.00M | 2.30M | 1.34M | 116.00K | -9.00K |
EBITDA Ratio | 5.53% | 4.11% | 4.55% | 3.09% | 3.12% | 1.90% | 2.55% | 2.44% | 1.74% | 1.91% | 2.04% | 0.00% |
Operating Income | 15.13M | 19.74M | 21.54M | 10.89M | 7.68M | 3.15M | 7.49M | 5.24M | 1.58M | 1.06M | 115.00K | -9.00K |
Operating Income Ratio | 1.89% | 2.65% | 2.91% | 2.13% | 1.92% | 0.79% | 1.77% | 1.84% | 1.20% | 1.47% | 2.02% | 0.00% |
Total Other Income/Expenses | 14.83M | -3.97M | -6.93M | -5.85M | -2.87M | 649.27K | -3.36M | -1.36M | -166.00K | 27.00K | 0.00 | 0.00 |
Income Before Tax | 29.96M | 15.77M | 14.61M | 5.04M | 4.81M | 4.75M | 4.88M | 3.88M | 1.41M | 1.06M | 115.00K | -9.00K |
Income Before Tax Ratio | 3.74% | 2.12% | 1.97% | 0.99% | 1.20% | 1.20% | 1.15% | 1.36% | 1.07% | 1.46% | 2.02% | 0.00% |
Income Tax Expense | 8.35M | 4.52M | 4.12M | 1.31M | 1.34M | 639.49K | 1.02M | 1.12M | 444.00K | 327.00K | 38.00K | -8.00K |
Net Income | 21.61M | 11.25M | 10.49M | 3.73M | 3.47M | 4.11M | 3.86M | 2.76M | 965.00K | 728.00K | 77.00K | -9.00K |
Net Income Ratio | 2.70% | 1.51% | 1.42% | 0.73% | 0.87% | 1.03% | 0.91% | 0.97% | 0.73% | 1.01% | 1.35% | 0.00% |
EPS | 0.25 | 1.94 | 0.18 | 0.07 | 0.07 | 0.11 | 0.10 | 0.07 | 0.03 | 0.02 | 0.00 | 0.00 |
EPS Diluted | 0.25 | 1.94 | 0.18 | 0.07 | 0.07 | 0.11 | 0.10 | 0.07 | 0.03 | 0.02 | 0.00 | 0.00 |
Weighted Avg Shares Out | 86.45M | 5.80M | 56.73M | 56.73M | 52.95M | 38.65M | 36.89M | 36.89M | 36.89M | 36.89M | 36.89M | 36.89M |
Weighted Avg Shares Out (Dil) | 86.45M | 5.80M | 56.73M | 56.73M | 52.95M | 38.65M | 36.89M | 36.89M | 36.89M | 36.89M | 36.89M | 36.89M |
Source: https://incomestatements.info
Category: Stock Reports